查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298232

斑块切除设备市场：按产品、最终用户：2021-2031 年全球机会分析和行业预测

Atherectomy Devices Market By Product, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 290 Pages | 商品交期: 2-3个工作天内

价格

2021年，全球旋切设备市场价值为7.8712亿美元，预计到2031年将达到21.1197亿美元，2022年至2031年的复合年增长率为10.5%。我来了。

斑块切除设备市场-IMG1

斑块切除装置是一种医疗装置，用于去除动脉中积聚的斑块，特别是在动脉硬化的情况下。 动脉粥样硬化是一种动脉疾病，其中脂肪沉积物(称为斑块)积聚在动脉内壁上，导致动脉狭窄和硬化。

斑块旋切设备是用于去除动脉壁上动脉粥样硬化斑块的医疗设备。 斑块旋切术装置通常与其他外周动脉疾病 (PAD) 治疗方法(例如球囊血管成形术和支架置入术)结合使用，以改善血流并缓解症状。 它通常在医院或门诊环境中进行，通常在局部麻醉下进行。 与所有医疗手术一样，旋切术也存在出血、感染和动脉损伤等风险。 然而，通过适当的患者选择和技术，斑块切除术可以成为外周动脉疾病(PAD)的安全有效的治疗方法。

由于动脉粥样硬化、冠状动脉疾病 (CAD) 和外周动脉疾病 (PAD) 等心血管疾病的发病率不断上升，对旋切设备的需求激增。 动脉粥样硬化是一种以动脉内斑块积聚为特征的疾病，导致动脉狭窄和硬化。 结果，流向心臟和大脑等重要器官的血液减少，这可能导致心脏病和中风等严重的健康问题。 此外，近年来，由于生活方式的改变和人口老龄化等多种因素，动脉硬化的患病率有所增加。 2021年，美国心臟协会报告称，动脉粥样硬化性下肢外周动脉疾病(PAD)是心血管疾病发病和死亡的重要原因，影响着全球超过2.3亿人，这一点正得到越来越多的认识。

此外，老年人更容易患心血管疾病和其他相关疾病，如糖尿病和高血压，因为随着年龄的增长，血管变得缺乏弹性、僵硬，无法根据需要伸展和收缩来调节血压。发展风险高 此外，一些老年人有心血管疾病(CVD)的遗传倾向，例如心脏病或中风的家族史。 此外，由于减轻疼痛、缩短住院时间和缩短恢復时间，对微创手术的需求不断增加，预计将在预测期内推动市场增长。

内容

第1章简介

第 2 章执行摘要

第3章市场概述

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争强度
  • 市场动态
    • 协调员
      • 外周动脉疾病 (PAD) 的患病率不断上升
      • 老年人口增加
      • 对微创手术的需求激增
    • 阻碍因素
      • 缺乏熟练的医疗保健专业人员
    • 机会
      • 旋切装置的技术进展
  • COVID-19 对市场的影响分析

第 4 章斑块切除设备市场：副产品

  • 概述
    • 市场规模和预测
  • 定向斑块旋切装置
    • 主要市场趋势、增长动力和机遇
    • 市场规模/预测：按地区划分
    • 市场份额分析：按国家/地区划分
  • 旋转斑块切除装置
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分
  • 眼眶斑块旋切装置
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分

第 5 章斑块切除设备市场：按最终用户划分

  • 概述
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分
  • 门诊手术中心
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区划分
    • 市场份额分析：按国家/地区划分

第 6 章：斑块切除设备市场：按地区

  • 概述
    • 市场规模/预测：按地区划分
  • 北美
    • 主要趋势和机遇
    • 市场规模/预测：按产品分类
    • 市场规模和预测：按最终用户划分
    • 市场规模/预测：按国家/地区划分
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
  • 欧洲
    • 主要趋势和机遇
    • 市场规模/预测：按产品分类
    • 市场规模和预测：按最终用户划分
    • 市场规模/预测：按国家/地区划分
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 欧洲其他地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
  • 亚太地区
    • 主要趋势和机遇
    • 市场规模/预测：按产品分类
    • 市场规模和预测：按最终用户划分
    • 市场规模/预测：按国家/地区划分
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 亚太地区其他地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
  • 拉丁美洲/中东/非洲
    • 主要趋势和机遇
    • 市场规模/预测：按产品分类
    • 市场规模和预测：按最终用户划分
    • 市场规模/预测：按国家/地区划分
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分
      • 其他地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按产品分类
      • 市场规模和预测：按最终用户划分

第7章竞争格局

  • 简介
  • 关键成功策略
  • 10家主要公司的产品图谱
  • 竞赛仪表板
  • 比赛热图
  • 顶级公司定位(2021 年)

第8章公司简介

  • Medtronic plc
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Becton, Dickinson and Company
  • AngioDynamics Inc.
  • Rex medical
  • Nipro Corporation
  • Invamed medical
  • Avinger Inc.
Product Code: A11505

The global atherectomy devices market was valued at $ 787.12 million in 2021 and is projected to reach $ 2111.97 million by 2031, registering a CAGR of 10.5% from 2022 to 2031.

Atherectomy Devices Market - IMG1

Atherectomy devices are medical devices used to remove plaque buildup in arteries, particularly in cases of atherosclerosis. Atherosclerosis is a disease of the arteries in which fatty deposits, known as plaques, build up on the inner walls of the arteries, leading to their narrowing and hardening.

Atherectomy devices are medical devices used to remove atherosclerotic plaque from the walls of arteries. Atherectomy devices are often used in conjunction with other treatments for peripheral artery disease (PAD), such as balloon angioplasty or stenting, to improve blood flow, and alleviate symptoms. They are typically performed in a hospital or outpatient setting and are usually done under local anesthesia. Like all medical procedures, atherectomy carries some risks, including bleeding, infection, and damage to the artery. However, with proper patient selection and technique, atherectomy can be a safe and effective treatment option for peripheral artery disease (PAD).

The surge in demand for atherectomy devices is due to rise in incidence of cardiovascular diseases, such as atherosclerosis, Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Atherosclerosis, which is a condition characterized by the buildup of plaque inside the arteries, leading to the narrowing and hardening of the arteries. This can result in reduced blood flow to vital organs such as the heart and brain, which can lead to serious health problems such as heart attacks and strokes. Furthermore, the prevalence of atherosclerosis has increased in recent years due to various factors, including changes in lifestyle and an aging population. In 2021, according to a report by American Heart Association, atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide.

Furthermore, the elderly population is at a higher risk of developing cardiovascular diseases and other related conditions, such as diabetes and hypertension due to the fact that blood vessels lose elasticity with age, becoming stiffer and less able to expand and contract as needed to regulate blood pressure. In addition, some elderly individuals may have a genetic predisposition to cardiovascular disease (CVDs), such as a family history of heart disease or stroke. Moreover, increase in demand for minimally invasive procedures due to reduced pain, shorter hospital stays, and faster recovery times is expected to drive the market growth during the forecast period.

In addition, the rise in healthcare expenditure in both developed and developing countries drives demand for atherectomy devices, as healthcare providers seek to offer the latest and most effective treatments to their patients. Thus, these were the major factors that contribute to the growth of the atherectomy devices market. However, factors such as high cost of atherectomy treatment, limited availability of skilled healthcare professionals, and risk of complications might restrain the growth of the atherectomy devices market.

The atherectomy devices market is segmented into type, end user, and region. By type, the market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global atherectomy devices market include: Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the atherectomy devices market analysis from 2021 to 2031 to identify the prevailing atherectomy devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the atherectomy devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global atherectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Rotational Atherectomy Devices
  • Orbital Atherectomy Devices
  • Others
  • Directional Atherectomy Devices

By End User

  • Hospitals
  • Ambulatory surgery centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

  • Medtronic plc
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Becton, Dickinson and Company
  • AngioDynamics Inc.
  • Rex medical
  • Nipro Corporation
  • Invamed medical
  • Avinger Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increasing prevalence of peripheral artery disease (PAD)
      • 3.4.1.2. Growth in geriatric population
      • 3.4.1.3. Surge in demand for minimally invasive procedures
    • 3.4.2. Restraints
      • 3.4.2.1. Limited availability of skilled healthcare professionals
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancement in Atherectomy devices
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ATHERECTOMY DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Directional Atherectomy Devices
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Rotational Atherectomy Devices
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Orbital Atherectomy Devices
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: ATHERECTOMY DEVICES MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Ambulatory surgery centers
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ATHERECTOMY DEVICES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Product
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Product
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Product
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Product
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Product
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Product
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Product
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Product
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Product
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Product
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Product
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Product
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Product
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Product
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Product
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Product
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Product
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Product
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Product
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Product
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Product
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Product
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Product
      • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Medtronic plc
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. Koninklijke Philips N.V.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
  • 8.4. Cardiovascular Systems, Inc.
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Becton, Dickinson and Company
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. AngioDynamics Inc.
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Rex medical
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Nipro Corporation
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Invamed medical
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
  • 8.10. Avinger Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 02. ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 07. ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. ATHERECTOMY DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 12. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 13. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. U.S. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 15. U.S. ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 16. CANADA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 17. CANADA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEXICO ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 19. MEXICO ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 21. EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. EUROPE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. GERMANY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 24. GERMANY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. FRANCE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 26. FRANCE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. UK ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 28. UK ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. ITALY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 30. ITALY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. SPAIN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 32. SPAIN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 34. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 37. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. CHINA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 39. CHINA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. JAPAN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 41. JAPAN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. INDIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. INDIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 45. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 46. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 47. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 51. LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. LAMEA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 53. BRAZIL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 54. BRAZIL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 58. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 60. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 62. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 63. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 64. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 65. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 66. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 67. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 68. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 69. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 70. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 71. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 72. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 73. CARDIOVASCULAR SYSTEMS, INC.: KEY EXECUTIVES
  • TABLE 74. CARDIOVASCULAR SYSTEMS, INC.: COMPANY SNAPSHOT
  • TABLE 75. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT SEGMENTS
  • TABLE 76. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT PORTFOLIO
  • TABLE 77. CARDIOVASCULAR SYSTEMS, INC.: KEY STRATERGIES
  • TABLE 78. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 79. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 80. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 81. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 82. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 83. ANGIODYNAMICS INC.: KEY EXECUTIVES
  • TABLE 84. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
  • TABLE 85. ANGIODYNAMICS INC.: PRODUCT SEGMENTS
  • TABLE 86. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
  • TABLE 87. ANGIODYNAMICS INC.: KEY STRATERGIES
  • TABLE 88. REX MEDICAL: KEY EXECUTIVES
  • TABLE 89. REX MEDICAL: COMPANY SNAPSHOT
  • TABLE 90. REX MEDICAL: PRODUCT SEGMENTS
  • TABLE 91. REX MEDICAL: PRODUCT PORTFOLIO
  • TABLE 92. NIPRO CORPORATION: KEY EXECUTIVES
  • TABLE 93. NIPRO CORPORATION: COMPANY SNAPSHOT
  • TABLE 94. NIPRO CORPORATION: PRODUCT SEGMENTS
  • TABLE 95. NIPRO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 96. INVAMED MEDICAL: KEY EXECUTIVES
  • TABLE 97. INVAMED MEDICAL: COMPANY SNAPSHOT
  • TABLE 98. INVAMED MEDICAL: PRODUCT SEGMENTS
  • TABLE 99. INVAMED MEDICAL: PRODUCT PORTFOLIO
  • TABLE 100. AVINGER INC.: KEY EXECUTIVES
  • TABLE 101. AVINGER INC.: COMPANY SNAPSHOT
  • TABLE 102. AVINGER INC.: PRODUCT SEGMENTS
  • TABLE 103. AVINGER INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ATHERECTOMY DEVICES MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF ATHERECTOMY DEVICES MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN ATHERECTOMY DEVICES MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALATHERECTOMY DEVICES MARKET
  • FIGURE 10. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 15. ATHERECTOMY DEVICES MARKET, BY END USER, 2021(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 19. ATHERECTOMY DEVICES MARKET BY REGION, 2021
  • FIGURE 20. U.S. ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 21. CANADA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 22. MEXICO ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. GERMANY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. FRANCE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. UK ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. ITALY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. SPAIN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. REST OF EUROPE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. CHINA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. JAPAN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. INDIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. AUSTRALIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SOUTH KOREA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. BRAZIL ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF LAMEA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: ATHERECTOMY DEVICES MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2021
  • FIGURE 46. MEDTRONIC PLC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 47. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 48. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 49. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 51. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 52. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. CARDIOVASCULAR SYSTEMS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. ANGIODYNAMICS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. NIPRO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. NIPRO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. NIPRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. AVINGER INC.: NET SALES, 2019-2021 ($MILLION)